We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Klaus Mergener

Klaus Mergener MD, PhD, MBA, MASGE

Affiliate Professor of Medicine, Division of Gastroenterology, University of Washington, Seattle, Washington

Dr. Klaus Mergener attended medical school in Frankfurt and Heidelberg, Germany, and at Duke University and Harvard University in the U.S. He completed his MD/PhD-thesis summa cum laude with 2008 Nobel Prize Laureate and molecular virologist Dr. Harald zur Hausen at the German Cancer Research Center in Heidelberg. He returned to Duke University for his residency in internal medicine and his fellowship training in gastroenterology and interventional endoscopy. He received his MBA from the University of Massachusetts at Amherst.

Dr. Mergener’s areas of clinical interest and expertise include interventional endoscopy, cancer prevention, biliary and pancreatic diseases. He has authored more than 100 articles and book chapters, and has presented invited lectures at regional, national, and international conferences. Dr. Mergener is the immediate Past-President of the American Society for Gastrointestinal Endoscopy (ASGE) and a former Associate Editor for Gastrointestinal Endoscopy. He is a past WA State Governor for the American College of Gastroenterology (ACG) and a current board member of the Pacific Northwest Gastroenterology Society.

Disclosures

Dr. Mergener reports the following:
  • Consultant: Boston Scientific, Pentax Medical, Ambu
  • Stock options: Kate Farms, Virgo Surgical Video Solutions